The U.S. cannabis industry continues expanding, creating opportunities for ancillary companies that support cultivation and retail operations the U.S. legal cannabis industry experienced significant growth, with sales reaching approximately $31.4 billion, marking a 9.14% increase from the previous year. Industry experts predict sales could reach $50 billion by 2028 as more states legalize marijuana. Recently, Congress discussed federal cannabis reform, increasing speculation about potential rescheduling. If federal legalization advances, ancillary stocks could see strong momentum. These companies provide essential products, including hydroponics, lighting, and packaging, benefiting from growing cannabis demand. As the industry evolves, investors are closely watching top-performing ancillary stocks this week.

To navigate cannabis stocks, investors should use technical analysis and risk management strategies. Identifying key support and resistance levels helps time entries and exits efficiently. Volume trends and moving averages also provide insight into stock momentum. Additionally, diversifying investments reduces risk in this volatile sector. As legalization efforts progress, tracking market sentiment and sector news remains essential.

Key Players in the Industry

The cannabis industry continues to expand in the U.S., creating strong demand for ancillary companies. These companies provide essential products and services to cannabis cultivators and dispensaries. With legalization efforts gaining traction, ancillary stocks could see significant growth in 2025.

This month, three top ancillary cannabis stocks stand out. GrowGeneration Corp. (GRWG) specializes in hydroponic and organic gardening products. Hydrofarm Holdings Group, Inc. (HYFM) supplies lighting, ventilation, and nutrients to cannabis growers. Scotts Miracle-Gro Company (SMG) dominates the lawn and garden market while expanding its cannabis-focused division. Each of these companies plays a vital role in the industry’s supply chain.

Investors should consider these stocks due to their strong market presence and financial performance. Let’s take a closer look at what makes each of them a top pick in March 2025.

[Read More]  3 Canadian Marijuana Stocks To Watch For Future Gains 2025

March 2025’s Top Ancillary Cannabis Stocks: Companies Powering the Green Industry

1. GrowGeneration Corp. (NASDAQ: GRWG)
2. Hydrofarm Holdings Group, Inc. (NASDAQ: HYFM)
3. Scotts Miracle-Gro Company (NYSE: SMG)

GrowGeneration Corp. (GRWG)

GrowGeneration Corp. (GRWG) is the largest hydroponics and specialty gardening retailer in the U.S. The company operates over 60 retail locations nationwide, supplying cannabis cultivators with nutrients, lighting, and grow tents. It has a strong presence in key cannabis markets, including California, Colorado, and Michigan. These states have established recreational and medical cannabis programs, making them critical to GrowGeneration’s success.

The company also sells its products online through its e-commerce platform. This has allowed it to reach customers beyond its physical locations. GrowGeneration continues to expand by acquiring smaller hydroponics companies and opening new stores in emerging markets. Its strong distribution network gives it an edge over competitors.

Financially, GrowGeneration has maintained stable revenue despite industry challenges. In its latest earnings report, the company reported $260 million in annual revenue. While this is a slight decline from previous years, cost-cutting measures have helped improve profitability.

Gross margins have remained strong at around 28%, showing efficient operations. The company has reduced operating expenses and streamlined its supply chain. These actions have helped maintain positive cash flow. Additionally, GrowGeneration’s e-commerce sales continue to grow, contributing to overall revenue stability.

Looking ahead, the company plans to focus on higher-margin products. It also aims to expand into new markets as more states legalize cannabis. With improving financials and strategic expansion, GrowGeneration remains a key ancillary stock to watch in 2025.

[Read More]  March 2025’s Top Cannabis Stocks: Key Players in the Growing Market

Hydrofarm Holdings Group, Inc. (HYFM)

Hydrofarm Holdings Group, Inc. (HYFM) is a leading supplier of hydroponic equipment and agricultural technology. The company provides lighting, climate control systems, and nutrients for indoor cannabis cultivation. It operates multiple distribution centers across North America, ensuring efficient delivery of products.

Hydrofarm’s largest presence is in the United States, where it serves commercial and home growers. The company’s products are widely used in California, Oregon, and Washington. These states have a strong cannabis cultivation industry, making them key markets for Hydrofarm.

The company has expanded its product portfolio through acquisitions of leading hydroponics brands, strengthening its position in the cannabis industry. It also continues to invest in research and development to improve its products.

Financially, Hydrofarm has faced challenges in recent years. However, its latest earnings report showed signs of recovery. The company reported $350 million in revenue, marking a 10% increase from the previous year. Cost reductions and supply chain improvements have contributed to better margins.

Despite previous losses, Hydrofarm has improved its cash flow and reduced debt. This financial discipline is helping the company stabilize its operations. The demand for hydroponic solutions remains high as cannabis cultivation expands.

Looking forward, Hydrofarm plans to introduce new energy-efficient lighting solutions. These innovations aim to reduce growers’ cultivation costs. The company also expects further growth from its commercial partnerships. Hydrofarm could see stronger financial performance in 2025 if the industry continues expanding.

[Read More]  3 Top Marijuana Stocks for Better Trading After Earnings

Scotts Miracle-Gro Company (SMG)

Scotts Miracle-Gro Company (SMG) is a lawn and garden care household name. While known for traditional gardening products, it has built a strong presence in the cannabis industry. Through its subsidiary, Hawthorne Gardening Company, Scotts provides lighting, fertilizers, and hydroponic systems for cannabis growers.

The company operates nationwide, with a significant presence in states like California, Colorado, and Michigan. Both home and commercial cannabis cultivators widely use its products. Hawthorne Gardening has become a market leader in hydroponic solutions, making Scotts a major ancillary cannabis stock.

In addition to its hydroponic business, Scotts continues expanding its organic and environmentally friendly product lines. This strategy aligns with increasing consumer demand for sustainable cultivation practices.

Financially, Scotts Miracle-Gro has maintained steady revenue growth. In its latest report, the company announced $4.2 billion in annual sales. This represents a slight increase from the previous year, driven by its Hawthorne division.

However, rising production costs have impacted overall profit margins. Scotts has responded by optimizing operations and streamlining product distribution. Despite economic challenges, it remains profitable, with strong cash reserves.

The company also continues to return value to shareholders through dividends and stock buybacks. Its diversified product portfolio provides stability in fluctuating markets. With continued investment in the cannabis sector, Scotts Miracle-Gro remains a strong pick for ancillary cannabis investors in 2025.

[Read More]  Here Are Ways To Profit With Marijuana Stocks While Volatility Is High

Must-Watch Ancillary Cannabis Stocks for Smart Investors

Ancillary cannabis stocks not only provide essential products and services to the growing cannabis industry but also play a vital role in its expansion. Companies like GrowGeneration, Hydrofarm, and Scotts Miracle-Gro have not only positioned themselves as industry leaders but have also built strong market presence. Because of this, their dominance in key U.S. cannabis markets makes them attractive investment options.

Even though the industry faces challenges, these companies continue to adapt by focusing on financial improvements, strategic expansions, and new product developments. As a result, their growth remains strong. Investors seeking exposure to the cannabis sector without directly investing in cultivation should seriously consider these ancillary stocks.

Furthermore, with increasing legalization and rising demand for cultivation products, these companies are set to benefit in 2025. Therefore, keeping an eye on their financial performance and market trends will help investors make informed decisions. Ultimately, as the cannabis industry evolves, ancillary stocks will remain crucial to its success.

The post March 2025 Watchlist: Top Ancillary Cannabis Stocks Poised for Growth appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Charlotte’s Web Holdings, Inc. (“Charlotte’s Web” or the “Company”), a market leader in full spectrum hemp extract wellness products, today reported financial results for the fourth quarter and year-ended December 31, 2024.

2024 Business Highlights

Achieved sequential quarterly revenue growth throughout 2024

Reduced operating expenses by over $22.4 million while strengthening operational performance

Successfully launched a new e-commerce platform with significantly enhanced capabilities

Expanded retail distribution, including 847 Walmart stores and now with a presence on Walmart.com, as well as Chewy.com, America’s largest online pet retailer

Introduced new product innovations, including functional mushroom gummies and CBD gel caps

Reduced operating expenses by over $22.4 million while strengthening operational performance

“2024 marked a turning point for Charlotte’s Web operationally as we delivered consecutive quarterly revenue growth, strengthened operations, and positioned the Company for sustained growth in 2025,” said Bill Morachnick, Chief Executive Officer of Charlotte’s Web. “With the successful launch of new product innovations, expanded retail partnerships, and transition underway to in-house manufacturing, we have laid the foundation for further strengthening the business in 2025. We’re particularly excited to announce that we will soon be offering our functional mushroom gummies on Amazon.com, representing our first meaningful presence on Amazon and introducing the Charlotte’s Web brand to millions of potential new customers. This not only diversifies our revenue streams but also reflects our commitment to access, including where consumers increasingly purchase health and wellness products. We are committed to delivering shareholder value through disciplined execution and continued expansion, evolving as a broader botanical wellness leader, beyond CBD.”

“Disciplined expense and cash flow management were top priorities throughout 2024,” added Erika Lind, Chief Financial Officer. “Our omnichannel strategy and operational optimization have been instrumental in navigating a complex regulatory environment while improving our cost structure. We executed significant expense reductions, reduced cash burn, and improved efficiencies across the business. The substantial improvement in our fourth quarter Adjusted EBITDA1 performance reflects the effectiveness of these measures, positioning us to continue reducing cash burn as we approach positive cash flow. We anticipate further improvements in 2025.”

2024 Business Review

Charlotte’s Web made significant strides in 2024, stabilizing its business and advancing strategic initiatives across product innovation, retail expansion, and operational efficiency.

Omnichannel Expansion and E-Commerce Growth
The Company’s new e-commerce platform, launched in mid-2024, improved site performance, enhanced the shopping experience and drove higher customer engagement. Advanced customer tools and marketing automation have increased conversion rates and sales volumes. New retail partnerships were added, including Walmart for topicals and Chewy.com for pet wellness products, further strengthening Charlotte’s Web’s national footprint. The transition toward an omnichannel model allows Charlotte’s Web to leverage direct-to-consumer (DTC), retail, and third-party platforms, streamlining distribution while broadening consumer accessibility.

New Product Innovations
New product innovations and categories included a successful expansion into minor cannabinoid CBN with the launch of Stay Asleep CBN Gummies, demonstrating strong demand for targeted botanical solutions and reinforcing Charlotte’s Web’s position in sleep wellness. In addition, launched in Q4 2024, Charlotte’s Web expanded into botanical wellness beyond CBD with functional mushroom gummies for focus, stress support, and energy.

Operational Efficiencies and Cost Management
Preparation for in-house manufacturing of gummies for full commercial production progressed in Q4 2024, with production ramp-up expected in 2025, improving margins and enhancing speed-to-market for future innovations. Expense reductions initiated in early 2024 materially lowered operating costs by $22.4 million, with similar spending continuing in 2025. The Company ended 2024 with $22.6 million in cash reserves, and the discipline of stringent expense management supports a strategic roadmap toward positive cash flow.

“With deeper retail penetration, new product categories, and improved operational efficiencies, we enter 2025 with momentum,” added Morachnick. “Charlotte’s Web is positioned to lead the next growth phase in botanical wellness while creating lasting value for shareholders.”

DeFloria Milestone
On February 24, 2025, the Company announced that the U.S. Food and Drug Administration (“FDA”) completed its review of the Phase 1 data and Investigational New Drug (“IND”) application submitted by DeFloria, Inc., an entity in which the Company is a stakeholder. The FDA has concluded that DeFloria may now proceed with the Phase 2 clinical trial for its botanical pharmaceutical candidate, AJA001 Oral Solution, a treatment for symptoms of autism spectrum disorder (“ASD”).

DeFloria is a collaboration between Charlotte’s Web, Ajna Biosciences, and British American Tobacco to develop AJA001 as a treatment for irritability associated with autism spectrum disorder. AJA001 employs the Company’s proprietary full-spectrum cannabidiol hemp extract derived from one of its patented cultivars. Charlotte’s Web has rights related to manufacturing for any eventual commercialization of AJA001 as an FDA-regulated botanical drug. Being the manufacturer of this product could represent a substantial long-term revenue opportunity for Charlotte’s Web upon potential FDA approval.

Financial Review

The following table sets forth selected financial information for the periods indicated:

Three months ended

Year ended

December 31,

December 31,

U.S. $ millions, except per share data

2024

2023

2024

2023

Revenue

$ 12.7

$ 15.9

$ 49.7

$ 63.2

Cost of goods sold

$ 7.6

$ 7.0

$ 28.4

$ 27.6

Gross profit

5.1

8.9

21.3

35.6

Selling, general and administrative expenses

10.6

18.6

53.3

75.6

Goodwill and asset impairments

–

0.6

–

0.6

Operating loss

(5.5)

(10.3)

(32.0)

(40.6)

Gain on initial investment in unconsolidated entity

–

–

–

10.7

Change in fair value of financial instruments and other

(0.1)

3.7

0.6

9.3

Other income (expense) , net

2.2

(1.4)

1.6

(2.7)

Income tax expense

–

(0.5)

–

(0.5)

Net loss

$ (3.4)

$ (8.5)

$ (29.8)

$ (23.8)

EPS basic and diluted

$ (0.02)

$ (0.06)

$ (0.19)

$ (0.16)

Adjusted EBITDA

$ 0.3

$ (6.5)

$ (12.6)

$ (22.7)

Assets:

Dec 31, 2024

Dec 31, 2023

Cash and cash equivalents

$ 22.6

$ 47.8

Total assets

$ 113.4

$ 152.5

Liabilities:

Long-term liabilities

$ 70.4

$ 73.3

Total liabilities

$ 86.4

$ 97.0

Fourth Quarter 2024 Financial Review

Consolidated net revenue for the fourth quarter ended December 31, 2024, was $12.7 million, compared to $15.9 million in the fourth quarter of 2023. Revenue increased modestly on a quarter-over-quarter basis versus Q3 2024 revenue of $12.6 million.

Quarterly revenue trend for 2024:

Q1

Q2

Q3

Q4

U.S. $ millions

2024

2024

2024

2024

Total revenue

$ 12.1

$ 12.3

$ 12.6

$ 12.7

In the fourth quarter, some retailers were negatively impacted by state regulations restricting the sale of certain CBD products, despite meeting federal requirements. However, e-commerce revenue increased quarter-over-quarter following the launch of the Company’s new e-commerce platform.

Gross Profit in Q4 2024 was $5.1 million, or 40.2% of revenue, compared to Gross Profit of $8.9 million, or 56.0% of revenue, in Q4 2023. The reduction in gross margin reflected holiday promotional investments, temporary shipping inefficiencies, and reduced fixed cost absorption on lower-than-expected revenue. The Company models gross margin to return above 50% in 2025.

Total selling, general, and administrative (“SG&A”) expenses in the quarter were $10.6 million, a 43% improvement from $18.6 million in Q4 2023. Stringent expense controls were implemented during the year to better align with current revenue levels.

Net loss for the fourth quarter of 2024 was $3.4 million, or ($0.02) per share basic and diluted, compared to a net loss of $8.5 million, or ($0.06) per share basic and diluted, for the fourth quarter of 2023.

Excluding depreciation, amortization and other non-cash items, Charlotte’s Web reported positive Adjusted EBITDA1 for the fourth quarter of 2024 of $0.3 million, a $6.8 million improvement compared to negative Adjusted EBITDA of $6.5 million in the fourth quarter of 2023.

Fiscal Year 2024 Financial Review
On a year-over-year basis, consolidated net revenue for the twelve months ended December 31, 2024, was $49.7 million, a decrease of 21.4% from $63.2 million in 2023. Revenue was negatively impacted by inflationary impacts on consumer spending and reduced retailer shelf allocations to the CBD category. The Company adopted a new e-commerce platform mid-year that has resulted in improving marketing, customer management, and sales volumes.

Gross profit for the year ended December 31, 2024, was $21.3 million, compared to $35.6 million for the year ended December 31, 2023. Gross profit was negatively impacted by a $4.1 million increase in inventory provision for 2024 due to the revaluation of aged hemp based on current market conditions. The increase was partially offset by lower inventory expenses and other variable costs associated with lower revenue in 2024. Gross profit before inventory provision was $25.4 million, or 51.1%, and $36.6 million, or 58.0%, in 2024 and 2023, respectively.

Total SG&A expense for 2024 was $53.3 million, compared to $75.6 million in the prior year. The $22.4 million or 29.6% decrease resulted from multiple actions taken in 2024 to reduce operating expenses and better align SG&A against the lower revenue levels, including workforce and insurance program adjustments, contract reviews and negotiations, and software optimizations. Additionally, in 2024, the Company amended its MLB Promotional Rights Agreement, resulting in a decrease in amortization and media expense related to MLB assets of approximately $4.9 million compared to 2023.

An operating loss of $32 million in 2024 improved 21.2% from an operating loss of $40.6 million in 2023. Net loss for 2024 was $29.8 million, or $(0.19) per share, basic and diluted, compared to a net loss of $23.8 million, or $(0.16) per share, basic and diluted, in 2023. The lower net loss in 2023 was due to a combined net gain of $20.0 million in that year in the fair value of the Company’s debt derivative and from its investment in DeFloria.

Excluding depreciation, amortization, and interest, the EBITDA1 loss for 2024 was $17.6 million, as compared to an EBITDA loss of $6.3 million for 2023. 2024 included a higher inventory provision than 2023, which included the combined net gain of $20.0 million in fair value of the Company’s debt derivative and from its investment in DeFloria. Excluding these items, the Adjusted EBITDA1 loss was $12.6 million for 2024, as compared to the Adjusted EBITDA loss of $22.7 million for 2023.

Balance Sheet and Cash Flow
Net cash used for operations in the fourth quarter of 2024 was $1.8 million. Net cash used for operations in the year ended December 31, 2024, was $21.2 million, including cash paid to MLB for license and media rights assets of $5 million. Capital expenditures of $3.9 million were primarily used for the in-house production of topical and gummy projects.

The Company’s cash and working capital as of December 31, 2024, were $22.6 million and $31.1 million, respectively, compared to $47.8 million and $54.5 million as of December 31, 2023, respectively.

“With reduced cash burn, having cash reserves exceeding $22 million provides the runway for 2025 growth and beyond,” said Mrs. Lind. “In-house production will increase in 2025, and continued expense discipline is key to stabilizing our financial position.”

Consolidated Financial Statements and Management’s Discussion and Analysis
The Company’s audited consolidated financial statements and accompanying notes for the three and twelve-month periods ended December 31, 2024, and 2023, and related management’s discussion and analysis of financial condition and results of operations (“MD&A”), are reported in the Company’s 10-K filing on the Securities and Exchange Commission website at www.sec.gov and on SEDAR+ at www.sedarplus.ca and will be available on the Investor Relations section of the Company’s website at https://investors.charlottesweb.com.

Analyst Conference Call
Management will host a conference call to discuss the Company’s 2024 fourth quarter and year-end results at 11:00 A.M. ET on March 19, 2025.

There are three ways to join the call:

Register and enter your phone number at https://emportal.ink/3EK35Bz to receive an instant automated call back, or

Dial 1-646-357-8785 or 1-800-836-8184 approximately 10 minutes before the conference call, or

Listen to the live webcast online.

Earnings Call Replay
A recording of the call will be available through March 26, 2025. To listen to a replay of the earnings call, please dial 1- 646-517-4150 or 1-888-660-6345 and provide conference replay ID 90317#. A webcast of the call will also be accessible through the investor relations section of the Company’s website for an extended period of time.

Subscribe to Charlotte’s Web investor news.

About Charlotte’s Web Holdings, Inc.
Charlotte’s Web Holdings, Inc., a Certified B Corporation headquartered in Louisville, Colorado, is the market leader in innovative hemp extract wellness products that include Charlotte’s Web whole-plant full-spectrum CBD extracts as well as broad-spectrum CBD certified NSF for Sport®. Charlotte’s Web branded premium quality full-spectrum CBD extract products start with proprietary hemp genetics that are North American farm-grown using organic and regenerative cultivation practices. The Company’s hemp extracts have naturally occurring botanical compounds including cannabidiol (“CBD”), CBN, CBC, CBG, terpenes, flavonoids, and other beneficial compounds. Charlotte’s Web product categories include CBD oil tinctures (liquid products), CBD gummies (sleep, calming, exercise recovery, immunity), CBN gummies, functional mushroom gummies, CBD capsules, CBD topical creams, and lotions, as well as CBD pet products for dogs. Through its substantially vertically integrated business model, Charlotte’s Web maintains stringent control over product quality and consistency with analytic testing from soil to shelf for quality assurance. Charlotte’s Web products are distributed to retailers and healthcare practitioners throughout the U.S.A. and online through the Company’s website at www.charlottesweb.com.

Shares of Charlotte’s Web trade on the Toronto Stock Exchange (TSX) under the symbol “CWEB” and are quoted in U.S. Dollars in the United States on the OTCQX under the symbol “CWBHF”.

Charlotte’s Web is the official CBD of Major League Baseball©.

© Major League Baseball trademarks and copyrights are used with permission of Major League Baseball. Visit MLB.com.

(1)

Non-GAAP Measures: The press release contains non-GAAP measures, including EBITDA and Adjusted EBITDA. Please refer to the section in the tables captioned “Non-GAAP Measures” below for additional information and a reconciliation to GAAP for all Non-GAAP metrics.

Forward-Looking Information
Certain information provided herein constitutes forward-looking statements or information (collectively, “forward-looking statements”) within the meaning of applicable securities laws. Forward-looking statements are typically identified by words such as “may”, “will”, “should”, “could”, “anticipate”, “expect”, “project”, “estimate”, “forecast”, “plan”, “intend”, “target”, “believe” and similar words suggesting future outcomes or statements regarding an outlook. Forward-looking statements are not guarantees of future performance and readers are cautioned against placing undue reliance on forward-looking statements. By their nature, these statements involve a variety of assumptions, known and unknown risks and uncertainties, and other factors which may cause actual results, levels of activity, and achievements to differ materially from those expressed or implied by such statements. The forward-looking statements contained in this press release are based on certain assumptions and analysis by management of the Company in light of its experience and perception of historical trends, current conditions and expected future development and other factors that it believes are appropriate and reasonable.

Specifically, this press release contains forward-looking statements relating to, but not limited to: organizational changes, marketing plans and operational platform upgrades, and the impact of these initiatives on retail expansion, operational efficiencies, cash flow,‎ revenue and e-commerce monetization; expectations relating to IT upgrades, marketing optimization and operational integrations; product expansion activities and the corresponding ‎results thereof; sales volume ad gross margin expectations; anticipated timing for, and business impact of, in-house manufacturing of topical ‎and gummy products; ‎the impact of the Company’s product innovations on product development; regulatory developments and the impact of developments on both consumer action and the Company’s opportunities and operations; activities relating to, and sponsorship of, legislation to advance regulatory framework; the impact of insourcing on operating margins, capital expenditures and R&D; anticipated consumer trends and corresponding product innovation; anticipated future financial results; the impact of the Company’s partnership with the MLB and PLL on the Company’s exposure and sales; the Company’s ability to increase online traffic and demographic exposure through new products and marketing; and the impact of certain activities on the Company’s business and financial condition and anticipated trajectory.

The material factors and assumptions used to develop the forward-looking statements herein include, but are not limited to: regulatory regime changes; anticipated product development and sales; the success of sales and marketing activities; product development and production expectations; outcomes from R&D activities; the Company’s ability to deal with adverse growing conditions in a timely and cost-effective manner; the availability of qualified and cost-effective human resources; compliance with contractual and regulatory obligations and requirements; availability of adequate liquidity and capital to support operations and business plans; and expectations around consumer product demand. In addition, the forward-looking statements are subject to risks and uncertainties pertaining to, among other things: supply and distribution chains; the market for the Company’s products; revenue fluctuations; regulatory changes; loss of customers and retail partners; retention and availability of talent; competing products; share price volatility; loss of proprietary information; product acceptance; internet and system infrastructure functionality; information technology security; available capital to fund operations and business plans; crop risk; economic and political considerations; and including but not limited to those risks and uncertainties discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ending December 31, 2024, and other risk factors contained in other filings with the Securities and Exchange Commission available on www.sec.gov and filings with Canadian securities regulatory authorities available on www.sedarplus.ca. The impact of any one risk, uncertainty, or factor on a particular forward-looking statement is not determinable with certainty as these are interdependent, and the Company’s future course of action depends on management’s assessment of all information available at the relevant time.

Any forward-looking statement in this press release is based only on information currently available to the Company and speaks only as of the date on which it is made. Except as required by applicable law, the Company assumes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. All forward-looking statements, whether written or oral, attributable to the Company or persons acting on the Company’s behalf, are expressly qualified in their entirety by these cautionary statements.

CHARLOTTE’S WEB HOLDINGS, INC.

CONSOLIDATED BALANCE SHEETS

(in thousands of U.S. dollars, except share and per share amounts)

December 31,

2024

2023

ASSETS

Current assets:

Cash and cash equivalents

$ 22,618

$ 47,820

Accounts receivable, net

1,263

1,950

Inventories, net

18,907

21,538

Prepaid expenses and other current assets

4,194

6,864

Total current assets

46,982

78,172

Property and equipment, net

26,337

27,513

License and media rights

13,691

17,070

Operating lease right-of-use assets, net

12,876

14,601

Investment in unconsolidated entity

10,800

11,000

SBH purchase option and other derivative assets

1,075

2,602

Intangible assets, net

1,049

887

Other long-term assets

632

703

Total assets

$ 113,442

$ 152,548

LIABILITIES AND SHAREHOLDERS’ EQUITY

Current liabilities:

Accounts payable

$ 3,426

$ 2,860

Accrued and other current liabilities

5,246

8,682

Lease obligations – current

2,055

2,252

License and media rights payable – current

5,209

9,852

Total current liabilities

15,936

23,646

Convertible debenture

43,631

42,528

Lease obligations

13,652

15,655

License and media rights payable

11,809

11,338

Derivative and other long-term liabilities

1,327

3,823

Total liabilities

86,355

96,990

Commitments and contingencies

Shareholders’ equity:

Common shares, nil par value; unlimited shares authorized; 158,009,541 and 154,332,366 shares issued and outstanding as of December 31, 2024 and 2023, respectively

1

1

Additional paid-in capital

328,655

327,280

Accumulated deficit

(301,569)

(271,723)

Total shareholders’ equity

27,087

55,558

Total liabilities and shareholders’ equity

$ 113,442

$ 152,548

CHARLOTTE’S WEB HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands of U.S. dollars, except share and per share amounts)

Year Ended December 31,

2024

2023

Revenue

$ 49,667

$ 63,155

Cost of goods sold

28,407

27,589

Gross profit

21,260

35,566

Selling, general and administrative expenses

53,247

75,630

Asset impairment

—

548

Operating loss

(31,987)

(40,612)

Gain on initial investment in unconsolidated entity

—

10,700

Change in fair value of financial instruments

615

9,339

Other income (expense), net

1,565

(2,694)

Loss before provision for income taxes

$ (29,807)

$ (23,267)

Income tax expense

(39)

(529)

Net loss

$ (29,846)

$ (23,796)

Per common share amounts

Net loss per common share, basic and diluted

$ (0.19)

$ (0.16)

CHARLOTTE’S WEB HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(in thousands of U.S. dollars, except share amounts)

Common Shares

Additional
Paid-in
Capital

Accumulated
Deficit

Total
Shareholders’
Equity

Shares

Amount

Balance—December 31, 2022

152,135,026

$ 1

$ 325,431

$ (247,927)

$ 77,505

Common shares issued upon vesting of restricted share units, net of withholdings

2,197,340

—

(251)

—

(251)

Share-based compensation

—

—

2,100

—

2,100

Net loss

—

—

—

(23,796)

(23,796)

Balance—December 31, 2023

154,332,366

$ 1

$ 327,280

$ (271,723)

$ 55,558

Common shares issued upon vesting of restricted share units, net of withholding

3,677,175

—

(145)

—

(145)

Share-based compensation

—

—

1,520

—

1,520

Net loss

—

—

—

(29,846)

(29,846)

Balance—December 31, 2024

158,009,541

$ 1

$ 328,655

$ (301,569)

$ 27,087

CHARLOTTE’S WEB HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands of U.S. dollars)

Year Ended December 31,

2024

2023

Cash flows from operating activities:

Net loss

$ (29,846)

$ (23,796)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation and amortization

9,979

15,160

Change in fair value of financial instruments

(615)

(9,339)

Gain on initial investment in unconsolidated entity

—

(10,700)

Convertible debenture and other accrued interest

3,724

3,857

Gain on foreign currency transaction

(3,631)

1,142

Share-based compensation

1,520

2,100

Changes in right-of-use assets

1,771

1,918

Allowance for credit losses

140

1,240

Inventory provision

4,154

1,039

Asset impairment

—

548

Other

611

3,313

Changes in operating assets and liabilities:

Accounts receivable, net

361

(809)

Inventories, net

(1,520)

4,376

Prepaid expenses and other current assets

1,332

85

Operating lease obligations

(2,247)

(2,304)

Accounts payable, accrued and other liabilities

(1,664)

151

License and media rights payable

(5,000)

(8,000)

Income tax and other receivable

—

4,261

Other operating assets and liabilities, net

(330)

372

Net cash used in operating activities

(21,261)

(15,386)

Cash flows from investing activities:

Purchases of property and equipment and intangible assets

(3,851)

(3,691)

Proceeds from sale of assets

55

185

Net cash provided by/(used in) investing activities

(3,796)

(3,506)

Cash flows from financing activities:

Other financing activities

(145)

(251)

Net cash used in financing activities

(145)

(251)

Net decrease in cash and cash equivalents

(25,202)

(19,143)

Cash and cash equivalents —beginning of year

47,820

66,963

Cash and cash equivalents —end of year

$ 22,618

$ 47,820

Non-cash activities:

Non-cash issuance of note receivable

—

(170)

Non-cash purchases of property and equipment and intangibles

(3)

(233)

(1) Non-GAAP Measures – EBITDA and Adjusted EBITDA
Earnings before interest, taxes, depreciation, and amortization (“EBITDA”) is not a recognized performance measure under U.S. GAAP. The term EBITDA consists of net loss and excludes interest, taxes, depreciation, and amortization. Adjusted EBITDA also excludes other non-cash items such as changes in fair value of financial instruments (Mark-to-Market), Share-based compensation, and impairment of assets. These non-GAAP financial measures should be considered supplemental to, and not a substitute for, our reported financial results prepared in accordance with GAAP. The non-GAAP financials measures do not have a standardized meaning prescribed under U.S. GAAP and therefore may not be comparable to similar measures presented by other issuers. The primary purpose of using non-GAAP financial measures is to provide supplemental information that we believe may be useful to investors and to enable investors to evaluate our results in the same way we do. We also present the non-GAAP financial measures because we believe they assist investors in comparing our performance across reporting periods on a consistent basis, as well as comparing our results against the results of other companies, by excluding items that we do not believe are indicative of our core operating performance. Specifically, we use these non-GAAP measures as measures of operating performance; to prepare our annual operating budget; to allocate resources to enhance the financial performance of our business; to evaluate the effectiveness of our business strategies; to provide consistency and comparability with past financial performance; to facilitate a comparison of our results with those of other companies, many of which use similar non-GAAP financial measures to supplement their GAAP results; and in communications with our board of directors concerning our financial performance. Investors should be aware, however, that not all companies define these non-GAAP measures consistently.

(1)

EBITDA and Adjusted EBITDA are non-GAAP financial measures with reconciliations provided in the table below:

Adjusted EBITDA for the three and twelve months ended December 31, 2024, and 2023 is as follows:

Charlotte’s Web Holdings, Inc.

Statement of Adjusted EBITDA

(In Thousands)

Three Months Ended

Year Ended

December 31,

December 31,

(unaudited)

(audited)

U.S. $ Thousands

2024

2023

2024

2023

Net loss

$ (3,371)

$ (8,589)

$ (29,846)

$ (23,796)

Depreciation of property and equipment and amortization of intangibles

2,473

3,650

9,979

15,160

Interest (income) expense

643

350

2,201

1,786

Income tax expense

(22)

529

39

529

EBITDA

(277)

(4,060)

(17,627)

(6,321)

Stock Comp

223

454

1,520

2,100

Mark-to-market financial instruments

86

(3,752)

(615)

(9,339)

Impairment

–

548

–

548

Inventory Provision

228

309

4,154

1,039

Initial gain on investment in DeFloria

–

–

–

(10,700)

Adjusted EBITDA

$ 260

$ (6,501)

$ (12,568)

$ (22,673)

View original content to download multimedia:https://www.prnewswire.com/news-releases/charlottes-web-reports-2024-fourth-quarter-and-year-end-financial-results-302405400.html

SOURCE Charlotte’s Web Holdings, Inc.

The post Charlotte’s Web Holdings, Inc. (CWBHF) Reports 2024 Fourth Quarter and Year-End Financial Results appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Marijuana stocks have been facing a downward trend in the market for some time. A big reason is regulatory uncertainty and reform issues. Legislative changes, particularly in major markets like the U.S., can greatly affect how shareholders think. Additionally, oversupply in certain regions has led to falling prices, which negatively affects revenue for companies in the sector. This has created a volatile sector where the trading behavior of the most public companies is more on the low end.

Yet this has also been an optimistic time where due to how low the sector is can be seen as a buying opportunity. Many see the future of cannabis as where the gains will lie. Although most of the cannabis sector is not trading well the industry as a whole is thriving. The cannabis industry continues to grow and show progress. In recent earning reports, most companies were able to show stronger profits and company gains. Still, this has not added much momentum to the public sector.

So with this most shareholders are preparing for the future and waiting for the moment to take profits. Now is a good time to do your research and follow the sector as much as you can. With cannabis still, a fairly young developing industry things can change for the better at any time. Below are several marijuana stocks to watch in today’s stock market.

Marijuana Stocks For Your 2025 Watch List

1. Aurora Cannabis Inc. (NASDAQ:ACB)
2. SNDL Inc. (NASDAQ:SNDL)
3. Cronos Group Inc. (NASDAQ:CRON)

Aurora Cannabis Inc.

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis derivative products in Canada and internationally. It has been some time since the company has released news.

Yet back on February 20th, 2025 the company announced the company’s extended pastille offerings in Australia. This development marks another meaningful step in Aurora’s deep commitment to offering patients premium medical cannabis products.

SNDL Inc.

SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments segments. In recent news, the company announced its Q4 2024 and full-year earnings.

Highlights And Key Mentions

• Net revenue for the fourth quarter of 2024 was $257.7 million, and $920.4 million for the full year of 2024,
• Gross profit also reached new records, with $68.8 million in the fourth quarter of 2024, and $240.3 million for the full year.
• Gross margin (1) of 26.7% in the fourth quarter of 2024 and 26.1% for the full year are also new records.
• Operating loss was $(76.1) million for the fourth quarter of 2024, driven by a negative valuation adjustment of the SunStream portfolio of $(65.7) million.
• Free cash flow (1) was positive both in the fourth quarter of 2024, at $11.6 million, and for the full year, at $8.9 million.

[Read More] Here Are Ways To Profit With Marijuana Stocks While Volatility Is High

Cronos Group Inc.

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production, and marketing of cannabis products in Canada, Israel, and Germany.

Recently the company announced the appointment of Anna Shlimak as CFO. Ms. Shlimak, who previously served as Cronos’ Chief Strategy Officer, will succeed James Holm.

[Read More] March 2025’s Top Cannabis Stocks: Key Players in the Growing Market

Words From The Company

“I am incredibly pleased Anna Shlimak is stepping into the Chief Financial Officer role,” said Mike Gorenstein, President and Chief Executive Officer, Cronos. “Anna has been an essential part of our senior leadership team.

The post 3 Canadian Marijuana Stocks To Watch For Future Gains 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to expand, creating opportunities for investors. In 2024, legal cannabis sales surpassed $30 billion, and analysts expect growth to reach $40 billion by 2025. Several states are pushing for new legalization measures, which could drive more revenue into the sector. Recently, lawmakers have discussed potential federal cannabis reform, including banking access and decriminalization efforts. This news has sparked renewed interest in marijuana penny stocks, which often see high volatility. These low-priced stocks can deliver significant gains but also have higher risks.

Investors should use technical analysis to identify potential entry points before making decisions. Support and resistance levels, moving averages, and trading volume can help confirm price trends. Proper risk management is also essential when trading volatile stocks. Setting stop-loss orders and managing position sizes can help limit losses. As market conditions shift, these penny stocks may offer opportunities for short-term gains in the cannabis sector.

The cannabis industry continues to show resilience despite recent market fluctuations. Many investors are watching for potential growth as legalization efforts progress. The U.S. cannabis market is projected to reach $40 billion by 2025, making it an attractive sector. Companies with strong market positions and expanding operations could see significant gains in the coming months.

This article highlights three top marijuana stocks to watch in March 2025. These companies have notable footprints in the U.S. cannabis industry. They also have strong financials that suggest growth potential. Here’s a closer look at Planet 13 Holdings Inc. (PLNHF), Glass House Brands Inc. (GLASF), and Cresco Labs Inc. (CRLBF).

[Read More] 3 Top Marijuana For Better Trading After Earnings

Top 3 Marijuana Stocks to Watch in March 2025

1. Planet 13 Holdings Inc. (OTC: PLNHF)
2. Glass House Brands Inc. (OTC: GLASF)
3. Cresco Labs Inc. (OTC: CRLBF)

Planet 13 Holdings Inc. (PLNHF)

Planet 13 Holdings Inc. is a well-known cannabis company focusing on superstore dispensaries. It operates some of the largest cannabis retail locations in the U.S. The company is best known for its Las Vegas Superstore, a massive dispensary with an immersive shopping experience.

Besides its flagship location, Planet 13 has expanded to California and Florida. In California, it operates a large dispensary in Santa Ana. The company is also developing additional stores in other high-traffic locations. With plans to expand further, Planet 13 aims to be a leader in the premium cannabis retail market.

Latest Financial Performance

Planet 13 reported strong revenue growth in its latest earnings report. In the most recent quarter, revenue reached $28.5 million, marking an increase from the previous year. This growth was driven by higher foot traffic and increased product offerings.

The company’s gross profit margin improved as well, reaching 50%. This was due to better cost management and strong sales of in-house brands. However, operating expenses remained high due to expansion efforts. Planet 13 continues investing in new locations to strengthen its market position.

Additionally, the company maintains a strong cash position. It holds over $45 million in cash and equivalents, which supports future growth plans. With a focus on innovation and customer experience, Planet 13 remains a stock to watch in the cannabis sector.

[Read More] Top Marijuana Stocks For Investors In The Cannabis Space

Glass House Brands Inc. (GLASF)

Glass House Brands Inc. is one of the largest vertically integrated cannabis operators in California. The company focuses on cultivation, processing, and retail sales. It owns and operates several high-tech greenhouses, producing premium cannabis at low costs.

Glass House’s largest cultivation facility is located in Santa Barbara, California. This greenhouse spans over 5.5 million square feet, making it one of the biggest in the U.S. The company also operates multiple dispensaries, including The Pottery and Farmacy locations. Glass House aims to expand further in California, focusing on low-cost production and high-quality products.

Latest Financial Performance

Glass House Brands recently reported record revenue growth. The company generated $50.2 million in quarterly revenue, representing a 45% year-over-year increase. This growth was fueled by higher production capacity and increasing retail sales.

The company’s gross profit margin also improved, reaching 38%. This was due to its low-cost cultivation strategy, which helps maintain strong profit margins. However, Glass House reported a net loss of $5.2 million, mainly due to expansion costs.

Despite the loss, Glass House remains financially strong. It holds $30 million in cash, providing flexibility for future investments. With its cost-efficient cultivation model, the company is well-positioned for long-term growth. Investors looking for exposure to the California market should keep an eye on this stock.

[Read More]  Top Ancillary Cannabis Stocks for March 2025: Growth Opportunities Ahead

Cresco Labs Inc. (CRLBF)

Cresco Labs Inc. is one of the largest multi-state cannabis operators (MSOs) in the U.S. The company focuses on both retail and wholesale cannabis sales, supplying dispensaries across multiple states. It operates under the Sunnyside brand, which has a strong presence in key markets.

Cresco has over 70 dispensaries in the U.S., with major operations in Illinois, Pennsylvania, and Florida. Illinois remains its largest market, benefiting from strong adult-use sales. The company also owns several cultivation and processing facilities, allowing it to control production costs. With ongoing expansion, Cresco continues to strengthen its market position.

Latest Financial Performance

Cresco Labs recently posted quarterly revenue of $188 million, a 12% increase compared to the previous year. This growth was driven by strong retail performance and expanding wholesale operations. The company remains one of the top-selling brands in the U.S. cannabis market.

The company’s gross profit margin improved to 53%, reflecting better cost management and higher sales volumes. However, net income remains negative, with a reported loss of $9.8 million. The company is working on reducing operational expenses to improve profitability.

Cresco also maintains a solid cash position, with $85 million in cash reserves. This financial stability allows the company to invest in expansion and strategic acquisitions. As one of the leading MSOs in the U.S., Cresco remains a top stock to watch in the cannabis sector.

[Read More] Here Are Ways To Profit With Marijuana Stocks While Volatility Is High

Investing in Cannabis: Strong Financials and Expansion Ahead

The cannabis industry is experiencing renewed interest as legalization efforts progress. Companies with strong market presence and efficient operations are best positioned for growth. Planet 13 Holdings, Glass House Brands, and Cresco Labs are three top stocks to watch in March 2025.

Each company has a unique business model and strong financials, making them attractive investment options. However, the cannabis market remains volatile, so investors should use technical analysis and risk management when considering these stocks. As the industry evolves, these companies could see significant growth in the coming months.

The post March 2025’s Top Cannabis Stocks: Key Players in the Growing Market appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The cannabis industry has seen significant changes and growth over the past few years. Especially with more than half of the US going legal. As well as other countries worldwide moving toward legalization for both medical and recreational use. Currently, several key trends and developments shape the industry. These trends can also impact the public sector and how marijuana stocks trade. More regions are legalizing cannabis, which expands the market and creates new business opportunities.

Recent legislation efforts in multiple states aim to regulate and tax cannabis sales. This will ultimately lead to significant tax revenue for local governments. With the industry as a whole still young and building, there are still many untapped niches within the industry. So this will allow for innovative companies to emerge, making it an opportune time for investors to start looking for top cannabis stocks to buy.

Learning the market and creating a game plan will be a big help when putting together a strategy. As more companies continue to report earnings we may see some momentum enter the cannabis sector. As with any investment, there are risks to consider, especially given regulatory changes and market volatility. However, for those willing to do their research and leverage opportunities, the cannabis industry can present promising prospects. The companies mentioned below are some marijuana stocks to watch this week.

Top Marijuana Stocks To Watch Today

1. Trulieve Cannabis Corp. (OTC:TCNNF)
2. Green Thumb Industries Inc. (OTC:GTBIF)
3. Greenlane Holdings, Inc. (NASDAQ:GNLN)

Trulieve Cannabis Corp.

Trulieve Cannabis Corp., together with its subsidiaries, operates as a cannabis retailer. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery.

Back on March 7th, the company announced the appointment of Ryan Blust, the Company’s Vice President of finance, as its interim Chief Financial Officer. This came as the departure of Wes Getman as Chief Financial Officer to pursue other opportunities, each effective March 6, 2025.

Words From The Company

“We thank Wes for his good work, particularly with his team implementing robust financial controls to meet Sarbanes Oxley requirements last year,” said Trulieve’s Chief Executive Officer Kim Rivers.”

Green Thumb Industries Inc.

Green Thumb Industries Inc. manufactures, distributes, markets, and sells cannabis products for medical and adult use in the United States.

It operates through two segments, Retail and Consumer Packaged Goods. In recent news, the company opened its sixth RISE Ohio location.

[Read More] Here Are Ways To Profit With Marijuana Stocks While Volatility Is High

Words From The President

“It is an exciting day for Green Thumb in the Buckeye State as we open our sixth RISE Dispensary in Ohio and first location in the Columbus area,” said Green Thumb President Anthony Georgiadis.

[Read More] Top Marijuana Stocks For Investors In The Cannabis Space

Greenlane Holdings, Inc.

Greenlane Holdings, Inc. engages in the development and distribution of cannabis accessories, vape devices, and lifestyle products in the United States, Canada, and Europe. It operates in two segments, Consumer Goods and Industrial Goods. Back on March 10th, the company announced the selection of Cannabis Creative Group.

This will be a division of CHAMP Digital an award-winning digital marketing agency. Specifically meant for  Cannabis and CBD. Headquartered in Boston, Cannabis Creative Group has client partnerships across North America, Mexico, and Europe.

The post 3 Top Marijuana For Better Trading After Earnings appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

There are several outlooks on how investors view marijuana stocks. This perception is based on various information and market behavior over the last several years. For the most part, a bulk of cannabis stock investors are frustrated. This comes from inconsistent trading patterns that have led to more downtrends. Much of this stems from issues with passing federal reform and establishing more efficient regulations in legal regions around the USA.

Right now, non-MSO legal operators in the US are having issues with competing due to high taxes and licensing fees. The smaller players are in a space known as small batch cultivators, farmers who handle the plant with care. Quality over quantity is how they run their ship, and for true cannabis customers, it’s the only way to go. Now, that is not to say that larger players like Curaleaf or Planet 13 Holdings are not feeling the struggle as well.

As a whole, the cannabis industry is still improving, but fear has been a huge hindrance in seeing stronger market action. With all the politics getting in the way, it has created aggressive, volatile action. Yet companies as a whole are profiting and continuing progress. Hopefully, this will once again transcend into better, more stable market action. Below are a few marijuana stocks to watch in the stock market this week.

Marijuana Stocks To Watch Today

1. Verano Holdings Corp. (OTC:VRNOF)
2. Jushi Holdings Inc. (OTC:JUSH)

Verano Holdings Corp.

Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States.

The company announced the launch of a wave of new product innovations across the fastest-growing categories in key markets.

Words From The Company

“As consumer appetite for differentiated cannabis products increases, particularly in the vape and pre-roll categories, we are excited to unleash a wave of innovation across our Savvy and (the) Essence portfolios featuring unique styles, experiences and engagement,” said David Spreckman, Verano Chief Marketing Officer.“

[Read More] 3 Marijuana Stocks To Watch This Month As Trading May Begin To Build

Jushi Holdings Inc.

Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. On March 6th the company reported its Q4 and full year 2024 financial results.

[Read More] 3 Marijuana Stocks For Investors To Get Excited About

Highlights And Key Mentions

• Total revenue of $65.9 million
• Gross profit and gross profit margin of $25.4 million and 38.6%, respectively,
• Net loss of $12.5 million
• Adjusted EBITDA1 and Adjusted EBITDA1 margin of $8.0 million and 12.2%, respectively
• Cash, cash equivalents and restricted cash were $21.3 million as of quarter end
• Net cash flows provided by operations of $7.2 million

The post Top Marijuana Stocks For Investors In The Cannabis Space appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Despite the battle to see progress for cannabis stocks in the market cannabis companies are generally doing well. Often in the form of revenue due to several factors. Which involves the progress of the legalization of marijuana for both recreational and medicinal use in various global regions. At this time the USA is the most dominant market for cannabis and has shown to be a growing space. Many companies are effectively scaling their operations, expanding their product lines, and tapping into new markets.

All of which help to drive up their sales and overall profitability. Additionally, as more states and countries legalize cannabis, the potential customer base continues to grow, contributing to a positive outlook for established businesses in the sector. This has led to many seeing the future of where the money lies for marijuana stock investors. Yes, you can and some have formed a strategy off of waiting for pop amid a volatile downtrend.

But most want consistent upward trading and momentum which is the outlook at this time. Speculation has led to more buying in hopes that things will rise for the sector. The disconnect between the financial health of cannabis companies and the performance of their stocks can often be attributed to external market pressures. In addition to investor sentiment that doesn’t always align with the company’s operational success. Still, there is more of a positive outlook for how things could be, and that is the focus for most marijuana stock investors. Here are a few marijuana stocks to watch this week in the stock market.

The Top Public Cannabis Companies To Know

1. GrowGeneration Corp. (NASDAQ:GRWG)
2. The Scotts Miracle-Gro Company (NYSE:SMG)

GrowGeneration Corp.

GrowGeneration Corp., through its subsidiaries, owns and operates retail hydroponic and organic gardening stores in the United States. On March 4th the company announced it will be attending the 37th Annual ROTH Conference on March 16-18, 2025.

The company has mentioned it will be participating in the ROTH Conference located in Dana Point, California. The Company will conduct 1×1 meetings during the conference. Investors interested in scheduling a meeting with GrowGen management can request a meeting through ROTH MKM.

[Read More] 3 Marijuana Stocks For Investors To Get Excited About

The Scotts Miracle-Gro Company

The Scotts Miracle-Gro Company, together with its subsidiaries, engages in the manufacture, marketing, and sale of products for lawn, garden care, and indoor and hydroponic gardening in the United States and internationally. The company recently announced it has partnered with Columbus City Schools and The Ohio State University Extension for a gardening program.

This program has led to students trying new, fresh foods and recipes. In other news The Scotts Miracle-Gro Company also selected Jim Safka to lead ecommerce initiatives. Safka is an accomplished executive with extensive and pioneering experience in technology, marketing and management.

[Read More] Best US Cannabis Stocks to Watch in March 2025 as the Industry Evolves

He previously served as CEO of Match.com, which grew by more than 20 percent annually under his leadership.

The post 2 Top Pot Stocks To Watch As More Companies Report Earnings appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The Canadian cannabis sector remains a key player in the global market. Many top Canadian companies are expanding into the U.S. in anticipation of future federal legalization. The U.S. cannabis industry continues to grow rapidly, with sales expected to surpass $40 billion in 2025. More states are legalizing cannabis, increasing market opportunities for Canadian producers. Recently, lawmakers introduced new federal reform bills that could ease banking restrictions and boost industry expansion. Investors are closely watching these developments as they could impact stock performance. With growing demand and regulatory progress, top Canadian cannabis stocks remain attractive.

However, market volatility requires a strong investment strategy. Using technical analysis helps identify key entry and exit points based on price trends. Watching moving averages, RSI levels, and trading volume can signal potential breakouts. Additionally, proper risk management is essential. Setting stop-loss orders and diversifying investments can help mitigate losses. By analyzing both fundamentals and technical indicators, investors can make informed decisions in this evolving sector.

The Canadian cannabis industry remains a critical player in the global marijuana market. With evolving regulations and expanding market opportunities, investors are keeping a close eye on top-performing stocks. Several Canadian cannabis companies also have significant operations in the U.S., positioning themselves for future federal legalization. Companies like Aurora Cannabis Inc. (ACB), Tilray Brands Inc. (TLRY), and Village Farms International Inc. (VFF) are among the strongest contenders.

Each of these companies has a unique business model, focusing on different aspects of the industry. Some specialize in medical cannabis, while others focus on recreational products and hemp-based offerings. Despite market volatility, these companies continue to adapt, striving for growth and profitability. Investors should monitor financial trends, expansion strategies, and regulatory updates. Below, we explore each of these top Canadian cannabis stocks, detailing their presence in the U.S. and their latest financial performance.

[Read More] Top Ancillary Cannabis Stocks for March 2025: Growth Opportunities Ahead

Top 3 Canadian Cannabis Stocks to Watch in March 2025

1. Aurora Cannabis Inc. (NASDAQ: ACB)
2. Tilray Brands Inc. (NASDAQ: TLRY)
3. Village Farms International Inc. (NASDAQ: VFF)

Aurora Cannabis Inc. (ACB)

Aurora Cannabis Inc. is one of Canada’s largest cannabis producers. The company focuses on both medical and recreational markets, with a strong presence internationally. While its primary operations remain in Canada, Aurora has been expanding into the U.S. market. Its focus in the U.S. revolves around medical cannabis and CBD products. The company operates through partnerships and acquisitions rather than direct dispensary ownership.

Aurora continues to target key states where medical cannabis is legal. The company is also positioning itself for potential federal legalization. Despite facing challenges in the past, it has restructured its operations to improve efficiency. Aurora’s business strategy includes reducing costs while expanding its product lineup. The company also has a strong foothold in Europe, further diversifying its revenue streams.

In its latest financial report, Aurora showed signs of stability. The company’s revenue remained steady, supported by medical cannabis sales. Its international operations, particularly in Europe, contributed significantly to growth. The company has also reduced its operational costs, improving its bottom line. Despite previous financial struggles, Aurora has maintained a healthy cash balance.

However, the company still faces challenges, including market competition and regulatory hurdles. Aurora continues to focus on profitability, aiming to achieve positive cash flow. It has implemented cost-saving initiatives and adjusted its pricing strategy. Investors should monitor upcoming earnings reports for further insights. If Aurora sustains its recent improvements, it could regain investor confidence.

[Read More] Best US Cannabis Stocks to Watch in March 2025 as the Industry Evolves

Tilray Brands Inc. (TLRY)

Tilray Brands Inc. is one of the most diversified cannabis companies in Canada. It operates across multiple segments, including medical cannabis, adult-use products, and hemp-based consumer goods. The company has also expanded its footprint in the U.S., particularly in the hemp and beverage industries. Tilray has acquired several U.S. companies to strengthen its position in the market.

The company has a growing presence in the U.S. through its wellness and CBD brands. It has also made strategic investments in the beverage sector. This includes partnerships with major alcohol companies to develop THC-infused drinks. While federal legalization remains uncertain, Tilray is positioning itself for future growth. The company aims to leverage its global presence to drive revenue.

Tilray’s latest financials highlight its expanding market reach. The company reported solid revenue growth, supported by strong international sales. It continues to see increased demand for its medical cannabis products. The company has also improved its gross margins through cost-cutting measures. Additionally, Tilray’s hemp and beverage divisions have shown promising performance.

Despite positive growth, the company faces challenges such as pricing pressure in Canada. The Canadian cannabis market remains highly competitive, affecting profit margins. However, Tilray’s global strategy helps offset some of these pressures. The company continues to focus on innovation, launching new products to attract consumers. If it maintains its current trajectory, Tilray could emerge as a long-term industry leader.

[Read More] 3 Marijuana Stocks To Keep On Your Radar 2025

Village Farms International Inc. (VFF)

Village Farms International Inc. is a unique player in the cannabis industry. Unlike traditional cannabis companies, it has a background in agriculture. The company transitioned from greenhouse-grown produce to cannabis cultivation. Its cannabis division, Pure Sunfarms, is one of Canada’s top producers.

Village Farms has also expanded into the U.S. hemp and CBD markets. It operates through its subsidiaries, focusing on high-quality cannabis and wellness products. The company has leveraged its agricultural expertise to lower production costs. This cost advantage allows it to compete effectively in both Canada and the U.S. Village Farms continues to explore potential opportunities in new markets.

Financially, Village Farms has shown resilience despite market fluctuations. The company recently reported strong revenue growth in its cannabis segment. Its profitability remains stable, supported by efficient operations. The company has successfully expanded its market share, particularly in Canada.

Village Farms has also managed to maintain a healthy balance sheet. Its focus on cost efficiency has helped sustain growth despite industry challenges. The company is actively seeking opportunities to expand its U.S. presence. If federal legalization progresses, it could significantly boost its long-term prospects. Investors should watch for continued expansion and financial performance improvements.

[Read More] 3 Marijuana Stocks To Watch This Month As Trading May Begin To Build

Best Canadian Marijuana Stocks to Watch as Industry Growth Accelerates

The Canadian cannabis market remains an exciting space for investors. While challenges persist, companies like Aurora Cannabis, Tilray Brands, and Village Farms continue to evolve. Their U.S. expansion and strategic investments position them well for future opportunities. Financial stability, market positioning, and regulatory updates will be key factors to watch.

Investors should stay informed about industry trends and company performance. Monitoring quarterly earnings and business strategies can provide valuable insights. As the cannabis sector grows, these Canadian stocks could offer promising investment opportunities.

The post High-Potential Canadian Cannabis Stocks to Watch This Month appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Marijuana stocks are still feeling the burden of industry concerns that have impacted trading. The bigger, more upfront issue is reform and regulatory matters. As well as fears of what will come with President Trump being in office and parts of his staff not on board with the legal market. Yet, as all of this stands true, cannabis companies continue to thrive and show large amounts of profitability.

This continuous success is creating positive speculation amid a downtrend. Now, this occurring because even with a drop in trading, legal operators are making money. So, when looking into the future, it gives hope that this progress will continue until trading changes. Many have been playing off this di,p finding top marijuana socks to buy while waiting for the sector to bounce. The bounce people are hoping for is not a volatile spike but a consistent trend of upward trading.

As most know, nothing is set in stone, and anything can happen in the public sector. One of the best ways to limit risk and maximize profits is to do your research and establish a trading plan. Having a trading strategy in place is what can help deliver a more successful portfolio down the line. Below are several marijuana stocks to watch that could soon see a better market performance.

Top Marijuana Stocks To Watch 2025

1. Innovative Industrial Properties, Inc. (NYSE:IIPR)
2. Chicago Atlantic Real Estate Finance, Inc. (NASDAQ:REFI)
3. NewLake Capital Partners, Inc. (OTC:NLCP)

Innovative Industrial Properties, Inc.

Innovative Industrial Properties, Inc. is a self-advised Maryland corporation focused on the acquisition, ownership and management of specialized properties leased to experienced, state-licensed operators for their regulated cannabis facilities. On February 19th the company reported its Q4 2024 results.

Highlights And Keymentions

• Total revenues of $308.5 million.
• Total revenues of $76.7 million for the quarter.
• Net income attributable to common stockholders of $159.9 million.
• Adjusted funds from operations (AFFO) of $256.1 million.
• Net income attributable to common stockholders of $39.5 million for the quarter, or $1.36 per share.
• AFFO of $63.4 million, or $2.22 per share.

[Read More] Investing in Cannabis: Best Canadian Stocks to Watch in March 2025

Chicago Atlantic Real Estate Finance, Inc.

Chicago Atlantic Real Estate Finance, Inc. operates as a commercial real estate finance company in the United States. In recent news the company announced Q4 2024 earnings.

Fourth Quarter 2024 Financial Results

• Net interest income of approximately $14.1 million as of December 31, 2024, compared to $14.5 million as of September 30, 2024.
• Interest expense decreased by approximately $0.4 million due to lower weighted average borrowings during the comparative period ending September 30, 2024.
• Total expenses of approximately $5.7 million before provision for current expected credit losses.
• On a fully diluted basis, there were 21,240,464 and 20,060,677 common shares outstanding as of December 31, 2024 and September 30, 2024, respectively.

[Read More] Top Ancillary Cannabis Stocks for March 2025: Growth Opportunities Ahead

NewLake Capital Partners, Inc.

NewLake Capital Partners, Inc. is an internally-managed real estate investment trust that provides real estate capital to state-licensed cannabis operators through sale-leaseback transactions and third-party purchases and funding for build-to-suit projects.

Recently the company announced that Anthony Coniglio, President and CEO, will present at the Sidoti Virtual Investor Conference. This investors conference is set to be held March 19-20, 2025.

The post 3 Marijuana Stocks For Investors To Get Excited About appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at the 37th Annual Roth Conference on Monday, March 17, 2025, at 1:00 PM PT.

About Cronos Group Inc.
Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com.

Forward-looking Statements
This press release may contain information that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws and court decisions (collectively, “Forward-looking Statements”). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include statements about Mr. Gorenstein’s intention to speak at the 37th Annual Roth Conference and Cronos’ intention to build an international iconic brand portfolio and develop disruptive intellectual property by advancing cannabis research, technology and product development. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, which has been filed on SEDAR+ and EDGAR and can be accessed at www.sedarplus.ca and www.sec.gov/edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.

Cronos Group Contact
Anna Shlimak
Investor Relations
Tel: (416) 504-0004
investor.relations@thecronosgroup.com

The post Cronos Group Inc. (CRON) to Speak at the 37th Annual Roth Conference appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..